CN Patent

CN106535884A — 免疫调节剂

Assigned to Eph Lexus Biosciences · Expires 2017-03-22 · 9y expired

What this patent protects

本申请描述了调节氧化还原酶吲哚胺2,3‑双加氧酶的化合物和含有所述化合物的组合物。本申请还提供了所述化合物和组合物用于治疗和/或预防由吲哚胺2,3‑双加氧酶介导的多种疾病、障碍和病症(包括癌症和免疫相关病症)的用途。

USPTO Abstract

本申请描述了调节氧化还原酶吲哚胺2,3‑双加氧酶的化合物和含有所述化合物的组合物。本申请还提供了所述化合物和组合物用于治疗和/或预防由吲哚胺2,3‑双加氧酶介导的多种疾病、障碍和病症(包括癌症和免疫相关病症)的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN106535884A
Jurisdiction
CN
Classification
—
Expires
2017-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Eph Lexus Biosciences
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.